asc.wiley-vch.de
1
1.22 (s, 6H, 2´4-CH3), 3.07 (s, 2H, CH2); 13C NMR (D2O): d =
28.2 (2´4-CH3), 44.0 (C4), 52.2 (C3), 173.3 (C1), 189.1 (C5),
(C4), 177.0 (C1), 184.0 (C5) ppm; the H NMR spectral data
recorded in NaOD are in agreement with those already pub-
lished by us.[16] 1H NMR (NaOD): d = 1.49 (s, 3H, CH3), 1.89
(dd, 1H, J = 11, 15 Hz, part of CH2), 2.43 (dd, J = 2, 15 Hz, part
of CH2), 3.55 (dd, 1H, J =2, 11 Hz, CH).
207.4 (C2); IR (neat): m = 2976.5, 1722.6, 1653.1, 1576.3 cm±1
.
2-Oxo-4-hydroxy-4-methylglutaric Acid
Dipotassium Salt (4)
(2S,4R)-4-Hydroxy-4-methyl-l-glutamic Acid (2b)
A solution of pyruvic acid (4 g, 45.4 mmol) in 50 mL of water
was adjusted to pH 12 with a 6 N KOH solution. After 30 min
of stirring, the pH is then adjusted to the neutrality by addi-
tion of a strong acidic ion exchange resin (Dowex 50WX8,
100 ± 200 mesh) and the resin removed by filtration. The
keto acid is dissolved in a hydro-methanolic solution (9:1,
methanol/water) and then purified by two precipitations in
diethyl ether to give a white solid; yield: 3.7 g (64%), that
was used for transamination without further purification;
spectroscopic data are in agreement with those reported by
Margolis et al.[17]
The transamination was carried out in the presence of
1.1 equivalent of CSA, and 2a and 2b were isolated with an
overall yield of 74%. Analysis of the NMR spectrum of the
mixture showed that the ratio 2a/2b is around 80:20. Separa-
tion of these two diastereoisomers was realized as pre-
viously described for a mixture of the four isomers.[20]
300 mg of the 2a/2b mixture were applied to a column
(50 cm long and 1 cm diameter) of a strong basic resin
(Dowex 2X8, 200 ± 400 mesh, acetate form). The column
was eluted with 0.5 M acetic acid and fractions of 5 mL col-
lected. 2b was eluted first in fractions 80 to 90, 2a appeared
in the fractions 91 to 105. The fractions were neutralized
with NaOH and the amino acids isolated after the usual
work-up. (application to a strong acidic resin and elution
with 1 M NH4OH). A pure sample of 2b was obtained and
characterized by comparison with an authentic sample al-
ready prepared by us.[16] [a]2D0: ±7.8° (c 0.6, 0.5 N NaOH);
1H NMR (D2O): d = 1.51 (s, 3H, CH3), 2.15 (dd, 1H, J = 9,
15 Hz, part of CH2), 2.39 (d, J = 15 Hz, part of CH2), 3.99 (d,
1H, J = 9 Hz, CH); 1H NMR (NaOD): d = 1.50 (s, 3H, CH3),
2.04 (dd, 1H, J =8, 15 Hz, part of CH2), 2.23 (dd, J =5, 15 Hz,
part of CH2), 3.65 (dd, 1H, J = 5, 8 Hz, CH) ppm.
General Procedure for the Transamination of
a-Keto Acids using Glutamic Oxalacetic
Transaminase (GOT)
To a 1 mmol solution of the a-keto acid dilithium salt in
50 mL of distilled water was added 1 mmol of cysteinesulfi-
nic acid monohydrate (CSA) and the pH was adjusted to 7.5
by addition of a 1 M NaOH solution. GOT (50 lL, 100 U) was
then added and the mixture was stirred during 24 h at 30 °C.
The product was purified through a 20-mL strong acidic re-
sin column (Dowex 50WX8, 16 ± 40 mesh, H+ form) and
eluted with 40 mL of a 1 M NH4OH solution. The alkaline
fractions were evaporated under reduced pressure and be-
low 40 °C (to avoid corresponding pyroglutamic acid forma-
tion) affording the amino acid as a zwitterion. The remain-
ing starting material can be recycled by evaporating the
acidic fractions from the resin up to 50 mL, adjusting the
pH to 7.5 with a 1 M NaOH solution and starting a new trans-
amination by adding the required quantity of enzyme.
References
[1] R. O. Duthaler, Tetrahedron 1994, 50, 1539±1650.
[2] G. Johnson, Bioorg. Med. Chem. Lett. 1993, 3, 9.
[3] (a) Z.-Q. Gu, D. P. Hesson, J. C. Pelletier, M. L. Mac-
caecchini, J. Med. Chem. 1995, 38, 2518±2519; (b) N.
Todeschi, J. Gharbi-Benarous, F. Acher, V. Larue, J.-P.
Pin, J. Bockaert, R. Azerad, J.-P. Girault, Bioorg. Med.
Chem. 1997, 5, 335±352.
4,4-Dimethyl-l-glutamic Acid (1)
The transamination was carried out as described above.
Compound 1 was isolated in 70% yield after one recycling.
[a]D20 : +33.3° (c1, 0.1 N HCl); 1H NMR (D2O): d = 1.26 and
1.30 (2´s, 2´3H, 2´CH3), 1.97 (dd, 1H, J = 2, 15 Hz, part of
CH2), 2.12 (dd, 1H, J = 9, 15 Hz, part of CH2), 3.79 (dd, 1H,
J = 2, 9 Hz, CH); 13C NMR (D2O): d = 26.1 and 31.1 (2´4-
CH3), 43.8 (C3), 45.9 (C4), 55.1 (C2), 178.5 (C1), 189.3 (C5);
IR (neat): m = 3500 ± 2500, 1584.1, 1521.6, 1404.9 cm±1; HRMS
(electrospray): calcd. for C7H14NO4 (M + H): 176.0923;
found: 176.0923.
[4] C. Najera, M. Yus, Tetrahedron: Asymmetry 1999, 10,
2245±2303.
[5] (a) M. Del Bosco, A. N. C. Johnstone, G. Bazza, S. Lo-
patriello, M. North, Tetrahedron 1995, 51, 8545±8554;
(b) S. Hanessian, R.-Y. Yang, Tetrahedron Lett. 1996,
50, 8997±9000; (c) E. Coudert, F. Acher, R. Azerad,
Synthesis 1997, 863±865; (d) A. Escribano, J. Ezquerra,
C. Pedregal, A. Rubio, B. Yruretagoyena, S. R. Baker,
R. A. Wright, B. G. Johnson, D. D. Schoepp, Bioorg.
Med. Chem. Lett. 1998, 8, 765±770.
[6] (a) A. M. P. Koskinen, H. Rapoport, J. Org. Chem. 1989,
54, 1859±1866; (b) V. Bavetsias, A. L. Jackman, J. H.
Marriot, R. Kimbell, W. Gibson, F. T. Boyle, G. M. F.
Bisset, J. Med. Chem. 1997, 40, 1495±1510.
[7] P. P. Taylor, D. P. Pantaleone, R. F. Senkpeil, I. G.
Fotheringham, Trends Biotechnol. 1998, 16, 412±418.
[8] (a) N. Passerat, J. Bolte, Tetrahedron Lett. 1987, 28,
1277±1280; (b) F. Echalier, O. Constant, J. Bolte, J.
Org. Chem. 1993, 58, 2747±2750; (c) V. Helaine, J. Ros-
si, J. Bolte, Tetrahedron Lett. 1999, 40, 6577±6580; (d)
(2S,4S)-4-Hydroxy-4-methyl-l-glutamic Acid (2a)
The transamination was carried out with only 0.4 equiva-
lents of CSA and 2a was isolated in 84% yield. [a]D20: ±3.7° (c
0.8, 0.5 N NaOH); HRMS (electrospray): calcd. for C6H12NO5:
178.0715; found: 178.0717; 1H NMR (D2O): d = 1.50 (s, 3H,
CH3), 2.05 (dd, 1H, J = 11, 15 Hz, part of CH2), 2.56 (dd, J =
2, 15 Hz, part of CH2), 3.71 (dd, 1H, J = 2, 11 Hz, CH);
13C NMR (D2O): d = 29.5 (4-CH3), 42.1 (C3), 55.2 (C2), 79.1
696
Adv. Synth. Catal. 2001, 343, 692±697